News | April 01, 2026
Rusan unveils APOSAN 3ml multi-dose pen
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
It promises fewer injections for vision loss patients
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
DiaMedica said it plans to launch the trial later in 2026
Subscribe To Our Newsletter & Stay Updated
